Walleye Trading LLC Allogene Therapeutics, Inc. Put Options Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $121,776 - $203,904	11,800 New	11,800 $127,000
Q2 2022 Aug 08, 2022	SELL	$6.78 - $12.28 $44,070 - $79,820	-6,500 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $49,725 - $99,385	6,500 New	6,500 $59,000
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $136,565 - $179,660	-6,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $150,336 - $229,119	6,400 Added 6400.0%	6,500 $170,000
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $1,839 - $5,404	100 New	100 $4,000

163

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $233M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.